Management of iatrogenic intravitreal triamcinolone acetonide.
Intravitreal corticossteroids have been used for therapeutic purposes in optimum doses and adverse reports have not been described. To best of our knowledge, this entity has never been reported as a problem. We report a case of successful management of iatrogenic intravitreal triamcinolone acetonide...
Main Authors: | Kumar Atul, Prakash Gunjan, Nainiwal Sanjeev |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2003-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2003;volume=51;issue=2;spage=180;epage=181;aulast=Kumar |
Similar Items
-
Persistent Depot of Triamcinolone Acetonide after a Single Intravitreal Injection
by: Vedantham Vasumathy, et al.
Published: (2005-03-01) -
Safety of intravitreal triamcinolone acetonide:an electrophysiologic and histopathological study in rabbits
by: Laila Hassan M. El-Shazly, et al.
Published: (2013-12-01) -
Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01) -
Effect of vitrectomy with intravitreal injection of triamcinolone acetonide in the treatment of proliferative diabetic retinopathy
by: Heng Li, et al.
Published: (2015-10-01) -
Intravitreal Triamcinolone Acetonide Presents a Diagnostic Challenge on Noncontrast Computed Tomography
by: Kinza T. Ahmad, et al.
Published: (2022-04-01)